English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Conference Paper

The Postmortem Human Brain to Characterize Novel Drug Targets for Psychiatric Disorders: Using FKBP5 as an Example

MPS-Authors
/persons/resource/persons202089

Matosin,  Natalie
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons222053

Martinelli,  Silvia
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons206456

Cruceanu,  Cristiana
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80272

Binder,  Elisabeth
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Matosin, N., Martinelli, S., Cruceanu, C., Turecki, G., & Binder, E. (2018). The Postmortem Human Brain to Characterize Novel Drug Targets for Psychiatric Disorders: Using FKBP5 as an Example. BIOLOGICAL PSYCHIATRY, 83(9), S28-S29.


Cite as: https://hdl.handle.net/21.11116/0000-0002-6A08-F
Abstract
There is no abstract available